Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2014, Article ID 790458, 5 pages
http://dx.doi.org/10.1155/2014/790458
Case Report

Grave’s Disease with Severe Hepatic Dysfunction: A Diagnostic and Therapeutic Challenge

Gauhati Medical College, Guwahati 781032, India

Received 23 April 2014; Revised 21 June 2014; Accepted 25 July 2014; Published 15 September 2014

Academic Editor: Gianfranco D. Alpini

Copyright © 2014 Ashok Krishna Bhuyan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Habershon, “Exophthalmic goitre , heart disease, jaundice, death,” The Lancet, vol. 1, p. 510, 1874. View at Google Scholar · View at Scopus
  2. M. G. Fischer, H. R. Nayer, and A. Miller, “Methimazole-induced jaundice,” Journal of the American Medical Association, vol. 223, no. 9, pp. 1028–1029, 1973. View at Publisher · View at Google Scholar · View at Scopus
  3. G. R. Doran, “Serum enzyme disturbances in thyrotoxicosis and myxoedema,” Journal of the Royal Society of Medicine, vol. 71, no. 3, pp. 189–194, 1978. View at Google Scholar · View at Scopus
  4. R. Malik and H. Hodgson, “The relationship between the thyroid gland and the liver,” QJM, vol. 95, no. 9, pp. 559–569, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Raviolo, M. Rizzetto, M. Tabone, M. De La Pierre, S. Recchia, and G. Verme, “Intrahepatic cholestasis in hyperthyroidism,” Recenti Progressi in Medicina, vol. 82, no. 6, pp. 319–323, 1991. View at Google Scholar · View at Scopus
  6. K. Hull, R. Horenstein, R. Naglieri, K. Munir, M. Ghany, and F. S. Celi, “Two cases of thyroid storm-associated cholestatic jaundice,” Endocrine Practice, vol. 13, no. 5, pp. 476–480, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. N. J. Greenberger, F. D. Milligan, L. J. DeGroot, and K. J. Isselbacher, “Jaundice and thyrotoxicosis in the absence of congestive heart failure. A study of four cases,” The American Journal of Medicine, vol. 36, no. 6, pp. 840–846, 1964. View at Publisher · View at Google Scholar · View at Scopus
  8. J. P. Crowe, E. Christensen, J. Butler et al., “Primary biliary cirrhosis: the prevalence of hypothyroidism and its relationship to thyroid autoantibodies and sicca syndrome,” Gastroenterology, vol. 78, no. 6, pp. 1437–1441, 1980. View at Google Scholar · View at Scopus
  9. E. L. Krawitt, “Autoimmune hepatitis,” The New England Journal of Medicine, vol. 334, no. 14, pp. 897–903, 1996. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Boelaert, P. R. Newby, M. J. Simmonds et al., “Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease,” The American Journal of Medicine, vol. 123, no. 2, pp. 183.e1–183.e9, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. A. J. Czaja, H. A. Carpenter, P. J. Santrach, and S. B. Moore, “Genetic predispositions for the immunological features of chronic active hepatitis,” Hepatology, vol. 18, no. 4, pp. 816–822, 1993. View at Publisher · View at Google Scholar · View at Scopus
  12. K. V. Williams, S. Nayak, D. Becker, J. Reyes, and L. A. Burmeister, “Fifty years of experience with propylthiouracil -associated hepatotoxicity: what have we learned?” Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 6, pp. 1727–1733, 1997. View at Google Scholar · View at Scopus
  13. M. Levy, “Propylthiouracil hepatotoxicity: a review and case presentation,” Clinical Pediatrics, vol. 32, no. 1, pp. 25–29, 1993. View at Publisher · View at Google Scholar · View at Scopus
  14. D. S. Cooper, “Treatment of thyrotoxicosis,” in Werner and Ingbar's the Thyroid, L. E. Braverman and R. D. Utiger, Eds., pp. 713–734, Lippincott-Rave, Philadelphia, Pa, USA, 7th edition, 1996. View at Google Scholar
  15. D. S. Cooper and S. A. Rivkees, “Putting propylthiouracil in perspective,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 6, pp. 1881–1882, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Ichiki, M. Akahoshi, N. Yamashita et al., “Propylthiouracil-induced severe hepatitis: a case report and review of the literature,” Journal of Gastroenterology, vol. 33, no. 5, pp. 747–750, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Nesseler, Y. Launey, C. Aninat, F. Morel, Y. Mallédant, and P. Seguin, “Clinical review: the liver in sepsis,” Critical Care, vol. 16, article 235, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. H. P. Dooner, J. Parada, C. Aliaga, and C. Hoyl, “The liver in thyrotoxicosis.,” Archives of Internal Medicine, vol. 120, no. 1, pp. 25–32, 1967. View at Publisher · View at Google Scholar · View at Scopus
  19. A. M. Choudhary and I. Roberts, “Thyroid storm presenting with liver failure,” Journal of Clinical Gastroenterology, vol. 29, no. 4, pp. 318–321, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. Y.-Z. Jiang, K. A. Hutchinson, P. Bartelloni, and C. A. Manthous, “Thyroid storm presenting as multiple organ dysfunction syndrome,” Chest, vol. 118, no. 3, pp. 877–879, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. M. A. Joffroy, “Hospice de la Salpetriere, Clinique Nerveuse, Legons faites en decembre,” in Le Progrès Medical, vol. 22, pp. 61–62, 2nd edition, 1891. View at Google Scholar
  22. H. Sattler, Basedow's Disease, Grune and Stratton, New York, NY, USA, 1908, English translation by G. W. Marchand and J. F. Marchland.
  23. H. P. Ludin, H. Spiess, and M. P. Koenig, “Neuromuscular dysfunction associated with thyrotoxicosis.,” European Neurology, vol. 2, no. 5, pp. 269–278, 1969. View at Publisher · View at Google Scholar · View at Scopus
  24. P. H. Chollet, P. J. Rigal, and L. Pigniole, “Une complication meconnue de l'hyperthyroidie: la neuropathie peripherique,” Presse Medicale, vol. 79, p. 145, 1971. View at Google Scholar